-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

SVB Leerink Maintains Outperform on Exact Sciences, Raises Price Target to $70

Benzinga · 01/06/2023 09:04
SVB Leerink analyst Puneet Souda maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $60 to $70.